Recurrent disease after apparent 'cure' of primary tumors is a common factor that contributes to cancer-associated mortality. A new study suggests that an inflammatory cytokine signature may provide a clinical indication of emergent recurrent disease and, accordingly, may suggest how to select and deliver therapy targeted against the secondary tumor (pages 1625–1631).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Werner, J. et al. Nat. Rev. Clin. Oncol. 10, 323–333 (2013).
Metzger-Filho, O. et al. J. Clin. Oncol. 31, 3083–3090 (2013).
Anders, C.K. & Carey, L.A. Clin. Breast Cancer 9 (suppl. 2), S73–S81 (2009).
Holohan, C., Van Schaeybroeck, S., Longley, D.B. & Johnston, P.G. Nat. Rev. Cancer 13, 714–726 (2013).
Hanahan, D. & Weinberg, R.A. Cell 144, 646–674 (2011).
de Visser, K.E., Eichten, A. & Coussens, L.M. Nat. Rev. Cancer 6, 24–37 (2006).
Hanahan, D. & Coussens, L.M. Cancer Cell 21, 309–322 (2012).
Coussens, L.M., Zitvogel, L. & Palucka, A.K. Science 339, 286–291 (2013).
Schreiber, R.D., Old, L.J. & Smyth, M.J. Science 331, 1565–1570 (2011).
Koebel, C.M. et al. Nature 450, 903–907 (2007).
Kottke, T. et al. Nat. Med. 19, 1625–1631 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Chan, C., Coussens, L. Poker face no more: cancer recurrence reveals its hand. Nat Med 19, 1569–1570 (2013). https://doi.org/10.1038/nm.3410
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3410
This article is cited by
-
A framework for the role of acute inflammation in tumor progression
Breast Cancer Research and Treatment (2015)